Parthenolide is able to influence the level of EMT-related proteins and to treat pulmonary fibrosis by affecting the progression of pulmonary fibrosis through the NF-κB/Snail signaling pathway [15]. Here, NFKB1 is linked to pulmonary fibrosis.